The Relationship Between Bone Metabolism and Peripheral Artery Disease in Patients on Hemodialysis: The Potential Role of Osteocalcin

References

• Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–1340. doi:10.1016/S0140-6736(13)61249-0
   PubMed Web of Science ®Google Scholar
• Writing Committee M, Gerhard-Herman MD, Gornik HL, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. Vasc Med. 2017;22(3):NP1–NP43. doi:10.1177/1358863X17701592
   PubMed Web of Science ®Google Scholar
• Abola MTB, Golledge J, Miyata T, et al. Asia-Pacific consensus statement on the management of peripheral artery disease: a report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee. J Atheroscler Thromb. 2020;27(8):809–907. doi:10.5551/jat.53660
   PubMed Web of Science ®Google Scholar
• Aktas G, Yilmaz S, Kantarci DB, et al. Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury? Postgrad Med. 2023;135(5):519–523. doi:10.1080/00325481.2023.2214058
   PubMed Web of Science ®Google Scholar
• Tekce H, Kin tekce B, Aktas G, Tanrisev M, Sit M. The evaluation of red cell distribution width in chronic hemodialysis patients. Int J Nephrol. 2014;2014:754370. doi:10.1155/2014/754370
   PubMedGoogle Scholar
• Rajagopalan S, Dellegrottaglie S, Furniss AL, et al. Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation. 2006;114(18):1914–1922. doi:10.1161/CIRCULATIONAHA.105.607390
   PubMed Web of Science ®Google Scholar
• Villain C, Ecochard R, Bouchet JL, et al. Relative prognostic impact of nutrition, anaemia, bone metabolism and cardiovascular comorbidities in elderly haemodialysis patients. Nephrol Dial Transplant. 2019;34(5):848–858. doi:10.1093/ndt/gfy272
   PubMed Web of Science ®Google Scholar
• Ambur V, Park P, Gaughan JP, et al. The impact of chronic kidney disease on lower extremity bypass outcomes in patients with critical limb ischemia. J Vasc Surg. 2019;69(2):491–496. doi:10.1016/j.jvs.2018.05.229
   PubMed Web of Science ®Google Scholar
• Ghimire M, Pahari B, Das G, Sharma SK, Das GC. Prevalence of Peripheral Arterial Disease (PAD) in End Stage Renal Disease (ESRD) patients on hemodialysis: a study from central Nepal. Kathmandu Univ Med J. 2014;12(47):181–184. doi:10.3126/kumj.v12i3.13714
   PubMedGoogle Scholar
• Kaminski MR, Raspovic A, McMahon LP, et al. Factors associated with foot ulceration and amputation in adults on dialysis: a cross-sectional observational study. BMC Nephrol. 2017;18(1):293. doi:10.1186/s12882-017-0711-6
   PubMed Web of Science ®Google Scholar
• Arroyo D, Betriu A, Valls J, et al. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study. Nephrol Dial Transplant. 2017;32(3):513–520. doi:10.1093/ndt/gfw039
   PubMed Web of Science ®Google Scholar
• Asceric RR, Dimkovic NB, Trajkovic GZ, et al. Prevalence, clinical characteristics, and predictors of peripheral arterial disease in hemodialysis patients: a cross-sectional study. BMC Nephrol. 2019;20(1):281. doi:10.1186/s12882-019-1468-x
   PubMedGoogle Scholar
• Lin WC, Tsai JP, Lai YH, et al. Serum osteoprotegerin level is positively associated with peripheral artery disease in patients with peritoneal dialysis. Ren Fail. 2020;42(1):131–136. doi:10.1080/0886022X.2020.1714654
   PubMed Web of Science ®Google Scholar
• Tian SL, Zhang K, Xu PC. Increased prevalence of peripheral arterial disease in patients with obese sarcopenia undergoing hemodialysis. Exp Ther Med. 2018;15(6):5148–5152. doi:10.3892/etm.2018.6002
   PubMed Web of Science ®Google Scholar
• Vuruşkan E, Saraçoğlu E, Küçükosmanoğlu M, Yavuz F, Kuzu Z, Sincer İ. Emergency endovascular treatment of peripheral arterial injuries occurring during the Syrian civil war: gaziantep Dr. Ersin Arslan Education and Research Hospital Experience. Anatol J Cardiol. 2016;16(4):298–304.
   Web of Science ®Google Scholar
• Rivero M, Nader ND, Blochle R, Harris LM, Dryjski ML, Dosluoglu HH. Poorer limb salvage in African American men with chronic limb ischemia is due to advanced clinical stage and higher anatomic complexity at presentation. J Vasc Surg. 2016;63(5):1318–1324. doi:10.1016/j.jvs.2015.11.052
   PubMed Web of Science ®Google Scholar
• Higashitani M, Uemura Y, Mizuno A, et al. Cardiovascular outcome and mortality in patients undergoing endovascular treatment for symptomatic peripheral artery disease- short-term results of the Toma-Code Registry. Circ J. 2018;82(7):1917–1925. doi:10.1253/circj.CJ-18-0105
   PubMed Web of Science ®Google Scholar
• Norvell DC, Thompson ML, Boyko EJ, et al. Mortality prediction following non-traumatic amputation of the lower extremity. Br J Surg. 2019;106(7):879–888. doi:10.1002/bjs.11124
   PubMed Web of Science ®Google Scholar
• Smith SL, Matthews EO, Moxon JV, Golledge J. A systematic review and meta-analysis of risk factors for and incidence of 30-day readmission after revascularization for peripheral artery disease. J Vasc Surg. 2019;70(3):996–1006 e7. doi:10.1016/j.jvs.2019.01.079
   PubMed Web of Science ®Google Scholar
• Ko T, Higashitani M, Uemura Y, et al. Clinical outcome and diverse risk factors for different therapeutic target locations of peripheral artery disease. J Atheroscler Thromb. 2020;27(8):769–779. doi:10.5551/jat.52647
   PubMed Web of Science ®Google Scholar
• Huang HL, Jimmy Juang JM, Chou HH, et al. Immediate results and long-term cardiovascular outcomes of endovascular therapy in octogenarians and nonoctogenarians with peripheral arterial diseases. Clin Interv Aging. 2016;11:535–543. doi:10.2147/CIA.S106119
   PubMed Web of Science ®Google Scholar
• Huang HL, Tzeng IS, Chou HH, et al. Contemporary cardiovascular outcomes in Taiwanese patients undergoing endovascular therapy for symptomatic lower extremity peripheral arterial disease. J Formos Med Assoc. 2020;119(6):1052–1060. doi:10.1016/j.jfma.2019.10.011
   PubMed Web of Science ®Google Scholar
• Otte J, van Netten JJ, Woittiez AJ. The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation. J Vasc Surg. 2015;62(2):406–411. doi:10.1016/j.jvs.2015.02.051
   PubMed Web of Science ®Google Scholar
• Bourrier M, Ferguson TW, Embil JM, Rigatto C, Komenda P, Tangri N. Peripheral artery disease: its adverse consequences with and without CKD. Am J Kidney Dis. 2020;75(5):705–712. doi:10.1053/j.ajkd.2019.08.028
   PubMed Web of Science ®Google Scholar
• Moussa Pacha H, Al-Khadra Y, Darmoch F, et al. In-hospital outcome of peripheral vascular intervention in dialysis-dependent end-stage renal disease patients. Catheter Cardiovasc Interv. 2020;95(3):E84–E95. doi:10.1002/ccd.28522
   PubMed Web of Science ®Google Scholar
• Anantha-Narayanan M, Sheikh AB, Nagpal S, et al. Systematic review and meta analysis of outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end stage renal disease. J Vasc Surg. 2020;73(1):331–340.e4. doi:10.1016/j.jvs.2020.08.032
   PubMed Web of Science ®Google Scholar
• Kaminski MR, Lambert KA, Raspovic A, et al. Risk factors for foot ulceration in adults with end-stage renal disease on dialysis: a prospective observational cohort study. BMC Nephrol. 2019;20(1):423. doi:10.1186/s12882-019-1594-5
   PubMed Web of Science ®Google Scholar
• Raikou VD, Kyriaki D. Factors related to peripheral arterial disease in patients undergoing hemodialysis: the potential role of monocyte chemoattractant protein-1. Hypertens Res. 2019;42(10):1528–1535. doi:10.1038/s41440-019-0259-x
   PubMed Web of Science ®Google Scholar
• Iannuzzo G, Forte F, Lupoli R, Di Minno MND. Association of Vitamin D deficiency with peripheral arterial disease: a meta-analysis of literature studies. J Clin Endocrinol Metab. 2018;103(6):2107–2115.
   Web of Science ®Google Scholar
• Wang Y, Feng T, Zhou H, Lu K, Bai Y, Zhang P. Vitamin D deficiency may not be an independent risk factor for peripheral arterial disease in middle-aged and elderly patients with type 2 diabetes in China. Dis Markers. 2020;2020:8854717. doi:10.1155/2020/8854717
   PubMed Web of Science ®Google Scholar
• Hsu YH, Yu HY, Chen HJ, Li TC, Hsu CC, Kao CH. The risk of peripheral arterial disease after parathyroidectomy in patients with end-stage renal disease. PLoS One. 2016;11(6):e0156863. doi:10.1371/journal.pone.0156863
   PubMed Web of Science ®Google Scholar
• Laucyte-Cibulskiene A, Petraviciute M, Gudynaite M, et al. Mismatch between stiffness in elastic and muscular arteries as a predictor of vascular calcification in dialysis patients. Aging Clin Exp Res. 2018;30(4):375–382. doi:10.1007/s40520-017-0787-7
   PubMed Web of Science ®Google Scholar
• Ishii T, Takabe S, Yanagawa Y, et al. Laser Doppler blood flowmeter as a useful instrument for the early detection of lower extremity peripheral arterial disease in hemodialysis patients: an observational study. BMC Nephrol. 2019;20(1):470. doi:10.1186/s12882-019-1653-y
   PubMed Web of Science ®Google Scholar
• Wang JS, Mazur CM, Wein MN. Sclerostin and osteocalcin: candidate bone-produced hormones. Front Endocrinol. 2021;12:584147. doi:10.3389/fendo.2021.584147
   PubMed Web of Science ®Google Scholar
• Berger JM, Karsenty G. Osteocalcin and the physiology of danger. FEBS Lett. 2022;596(5):665–680. doi:10.1002/1873-3468.14259
   PubMed Web of Science ®Google Scholar
• Wu J, Dou Y, Liu W, Zhao Y, Liu X. Osteocalcin improves outcome after acute ischemic stroke. Aging. 2020;12(1):387–396. doi:10.18632/aging.102629
   PubMedGoogle Scholar
• Han KH, Hennigar RA, O’Neill WC. The association of bone and osteoclasts with vascular calcification. Vasc Med. 2015;20(6):527–533. doi:10.1177/1358863X15597076
   PubMed Web of Science ®Google Scholar
• Rashdan NA, Sim AM, Cui L, et al. Osteocalcin regulates arterial calcification via altered wnt signaling and glucose metabolism. J Bone Miner Res. 2020;35(2):357–367. doi:10.1002/jbmr.3888
   PubMed Web of Science ®Google Scholar
• Xia LM, Zhang AP, Zheng Q, et al. Quercetin‑3‑O‑β‑D‑glucuronide inhibits mitochondria pathway‑mediated platelet apoptosis via the phosphatidylinositol‑3‑kinase/AKT pathway in immunological bone marrow failure. World J Tradit Chin Med. 2022;8(1):115–122. doi:10.4103/wjtcm.wjtcm_44_21
   Google Scholar